Concepedia
Statistics
Publications
22
Citations
1.7K
H-Index
19
Active since
1986
Affiliations
Mitsubishi Tanabe Pharma Corporation(Current)
Mitsubishi Group (Japan)
Tanabe Research Laboratories
Teikoku Seiyaku (Japan)
University of Tsukuba
Kenji Arakawa is an author at Mitsubishi Tanabe Pharma Corporation specializing in diabetes mellitus, pharmacology, and medicine.
Publications per year
1986–2022
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
Akira Oku, Kiichiro Ueta, Kenji Arakawa et al. · Diabetes · 1999 · 253 citations
Medicine, Pharmacology, Pharmacotherapy +17
Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models
Yin Liang, Kenji Arakawa, Kiichiro Ueta et al. · PLoS ONE · 2012 · 243 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na<sup>+</sup>‐glucose cotransporter inhibitor T‐1095
Kenji Arakawa, Tomomi Ishihara, Akira Oku et al. · British Journal of Pharmacology · 2001 · 161 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus
Hiroyuki Tanaka, Kazuhiko Takano, Hiroaki Iijima et al. · Advances in Therapy · 2016 · 141 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +14
Species differences in lipid peroxide levels in lung tissue and investigation of their determining factors
Kenji Arakawa, Masaru Sagai · Lipids · 1986 · 120 citations
Life Sciences, Biochemistry, Cellular Metabolism +15
1–5 of 22